<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Valdecoxib</id>
	<title>Valdecoxib - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Valdecoxib"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Valdecoxib&amp;action=history"/>
	<updated>2026-04-27T01:32:07Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Valdecoxib&amp;diff=5368153&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Valdecoxib&amp;diff=5368153&amp;oldid=prev"/>
		<updated>2024-03-06T03:33:37Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Valdecoxib.png|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Valdecoxib&amp;#039;&amp;#039;&amp;#039; is a [[nonsteroidal anti-inflammatory drug]] (NSAID) that was used in the treatment of [[osteoarthritis]], [[rheumatoid arthritis]], and [[menstrual pain]]. It is a selective [[COX-2 inhibitor]] that was marketed under the brand name &amp;#039;&amp;#039;&amp;#039;Bextra&amp;#039;&amp;#039;&amp;#039; by [[Pfizer]].&lt;br /&gt;
&lt;br /&gt;
== History ==&lt;br /&gt;
Valdecoxib was approved by the [[Food and Drug Administration]] (FDA) in the United States in 2001. However, it was withdrawn from the market in 2005 due to concerns about an increased risk of [[heart attack]] and [[stroke]], as well as serious skin reactions.&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
Valdecoxib works by inhibiting the enzyme [[cyclooxygenase-2]] (COX-2), which is involved in the production of [[prostaglandins]]. Prostaglandins play a key role in the body&amp;#039;s inflammatory response. By inhibiting COX-2, valdecoxib reduces inflammation and pain.&lt;br /&gt;
&lt;br /&gt;
== Side Effects ==&lt;br /&gt;
Common side effects of valdecoxib include [[nausea]], [[diarrhea]], and [[abdominal pain]]. Serious side effects can include an increased risk of heart attack and stroke, especially in those with pre-existing heart disease or risk factors for heart disease. Valdecoxib can also cause serious skin reactions, including [[Stevens-Johnson syndrome]] and [[toxic epidermal necrolysis]].&lt;br /&gt;
&lt;br /&gt;
== Withdrawal from Market ==&lt;br /&gt;
In April 2005, the FDA requested that Pfizer withdraw valdecoxib from the market. This decision was based on the results of a study that showed an increased risk of heart attack and stroke in patients taking valdecoxib, as well as reports of serious skin reactions. Pfizer complied with the FDA&amp;#039;s request and voluntarily withdrew valdecoxib from the market.&lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
* [[Nonsteroidal anti-inflammatory drug]]&lt;br /&gt;
* [[COX-2 inhibitor]]&lt;br /&gt;
* [[Pfizer]]&lt;br /&gt;
* [[Food and Drug Administration]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Nonsteroidal anti-inflammatory drugs]]&lt;br /&gt;
[[Category:COX-2 inhibitors]]&lt;br /&gt;
[[Category:Withdrawn drugs]]&lt;br /&gt;
{{Pharmacology-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>